Yep- not much homework done to prep for that interview but as another poster mentioned- that makes it interesting to think about what the interviewer was actually told. Sounds like it was very positive. Plus- with folks not having heard of leronlimab before - they might have those same 'basic' questions.

Seems believable that - as they (was it BP?) say - the media is about 3 or 4 months behind. With that timing- it looks we only have a few weeks left for them to catch up and start to get it.

While a bit off- this was so dang good; have the same thinking about the SP for that and a couple more reasons . . .

- Dr. Pourhassan's response to the Trump question was awesome. (He didn't make the interviewer feel like it was a dumb question. I was almost expecting him to wink when he was saying ' I am not sure . . .' and went on target.)

- The interviewer was enthusiastic and respectful; imo Cavuto had seemed almost indifferent.

- A picture of a relaxed someone getting a shot was shown during part of it.

- The intro sure seemed like an attention grabber: 1st to receive a phase 3 clinical trial approval from DSMC . . . Folks listening may not know what that means exactly- but they hear 'the 1st' related to a covid treatment.

- At the end of the IV, Dr. Pourhassan was given a 'full speed ahead- we can't get this out there soon enough' and two congratulations.

I put in my order for more - at above the asking price- as a result of this and the CC. (Pretty tapped out- but at this price- getting closer to the target.)